Results for leaflets translation from French to Greek

number of publications produced (reports, leaflets newsletters, leaflets, audio-visual material etc.)
Αριθμός δημοσιεύσεων (εκθέσεων, ειδησεογραφικών δελτίων, φυλλαδίων, οπτικοακουστικού υλικού κ.λπ.).

titre du document note for guidance on the clinical investigation of plasma derived fibrin sealants note for guidance on the clinical investigation of von willebrand factor warning on transmissible agents for patient leaflets and spcs core spc for plasma derived fibrin sealants
Τίτλος εγγράφου note for guidance on the clinical investigation of plasma derived fibrin sealants note for guidance on the clinical investigation of von willebrand factor warning on transmissible agents for patient leaflets and spcs core spc for plasma derived fibrin sealants

you may also choose to open a bank account in germany ( leaflets on the various banks are available at the staff info point on the 12th floor of the eurotower ) .
you may also choose to open a bank account in germany ( leaflets on the various banks are available at the staff info point on the 12th floor of the eurotower ) .

core summary of product characteristics for hepatitis b immunoglobulin revision of core summary of product characteristics for human normal immunoglobulin for intravenous use – addition of indication for treatment of parvovirus b19 infection revision of core summary of product characteristics for human plasma derived factor vii products and human plasma prothrombin complex revision of core summary of product characteristics for factor viii inhibitor bypassing fraction warning on transmissible agents for patient leaflets and summary of product characteristics revision of core summary of product characteristics for human anti-d immunoglobulin for intravenous and/ or intramuscular use (cpmp/ bpwg/ 574/ 99)
core summary of product characteristics for hepatitis b immunoglobulin revision of core summary of product characteristics for human normal immunoglobulin for intravenous use – addition of indication for treatment of parvovirus b19 infection revision of core summary of product characteristics for human plasma derived factor vii products and human plasma prothrombin complex revision of core summary of product characteristics for factor viii inhibitor bypassing fraction warning on transmissible agents for patient leaflets and summary of product characteristics revision of core summary of product characteristics for human anti- d immunoglobulin for intravenous and/ or intramuscular use (cpmp/ bpwg/ 574/ 99)